Exclusive

Publication

Byline

Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascendi... Read More


Singapore Clinical Trial: A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant V... Read More


Singapore Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway ... Read More


Singapore Clinical Trial: CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety... Read More


Singapore Clinical Trial: A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lutetium-177 (177Lu) Rosopatamab Tetraxetan in Combination with Standard of Care Versus Standard of Care Alone in Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Receptor Pathway Inhibitor (ARPI) Treatment

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lut... Read More


Telangana SIR: Congress, AIMIM targeting Hindu votes, says Bandi Sanjay

Hyderabad, July 5 -- Union Minister of State for Home Affairs Bandi Sanjay Kumar on Saturday, July 4, alleged that the Telangana government was misusing the Special Intensive Revision (SIR) exercise a... Read More


Young lecturer brings AI, robotics into vocational education

An Giang, July 5 -- Amid the hum of machinery and the rhythmic movements of robotic arms in the training workshop of An Giang Vocational College in An Giang province, lecturer Nguyen Duc Tai patiently... Read More


9 life skills you need to master on your own to feel more content

India, July 5 -- While friends, family, mentors, and teachers can offer guidance, but certain lessons can only be learned through your own experiences. These are the skills that help you stay content ... Read More


FIFA World Cup 2026: Haaland's brace stuns Brazil as Norway reach maiden quarter-finals

New York, July 5 -- Erling Haaland produced a sensational late double as Norway shocked five-time champions Brazil 2-1 in the FIFA World Cup 2026 Round of 16 at MetLife Stadium on Sunday, booking a pl... Read More


Sunita Ahuja refuses to eat food, says Govinda told her not to go in Lock Upp: 'The soup tastes like cow's piss'

India, July 5 -- Sunita Ahuja, wife of actor Govinda, is currently participating as one of the contestants in the reality show Lock Upp, co-hosted by Farah Khan and Riteish Deshmukh. Sunita got angry... Read More